Protocol + Context
Define indication, biomarker, phase, geography, decision question, materials, and success criteria.
HOW IT WORKS
Machine-assisted speed. Clinical review. Visible uncertainty.
The workflow separates evidence retrieval and relationship mapping from evidence quality, clinical plausibility, contradiction review, and final sponsor judgment.
From protocol context to decision-ready output.
Every stage keeps a trace back to the underlying evidence and the decision question that made it relevant.
Public Oncology Evidence Graph
Resolve trials, exact sites, investigators, publications, sponsors, competitive activity, and time.
Intelligence Logic
Retrieve, connect, compare, and rank with protocol-fit, time-aware lineage, and contradiction-aware logic.
Clinical & Evidence Review
Verify sources and entities, test clinical plausibility, inspect conflicts, and adjust confidence.
Decision-Ready Output
Deliver the reviewed ranking, rationale, confidence, gaps, diligence questions, and next action.
CLEAR DIVISION OF LABOR
AI accelerates the evidence work. Reviewers remain accountable for interpretation.
The system is designed to expose what the model used and where human judgment changed the interpretation.
Machine-assisted
- Evidence retrieval
- Entity resolution
- Relationship mapping
- Comparison and ranking
- Change detection
Clinically reviewed
- Source and entity verification
- Clinical plausibility
- Contradiction review
- Confidence adjustment
- Recommendation and boundary review
FROM DIFFERENCE TO DECISION
Disagreement becomes the diligence plan.
The goal is not to force consensus. It is to identify which divergence can materially change the decision and what should be validated next.
Existing View
Sponsor, CRO, or internal hypothesis and shortlist.
Independent Intelligence
Version-locked OncoLattice evidence signal.
Clinical Evidence
An orthogonal layer where relevant and permitted.
Reconcile
Shared, unique, conflicting, unsupported, and still unknown.
Feasibility Questions
Patient pool, PI bandwidth, competition, capacity, activation, and operational fit.
Decision
Sponsor or CRO authority sets the course and owns execution.
OncoLattice prioritizes validation questions; sponsor and CRO teams conduct forward-looking feasibility and make the final decision.
START WITH ONE DECISION
A focused pilot begins with a fixed question.
The first engagement is designed to produce an independent signal that can be compared with the sponsor's or CRO's current view.
Outputs are for strategic planning and do not guarantee patient availability, enrollment, site performance, regulatory outcomes, or clinical success.